Gastrointestinal motility and prokinetics in the critically ill

被引:52
|
作者
Chapman, Marianne J.
Nguyen, Nam Q.
Fraser, Robert J. L.
机构
[1] Royal Adelaide Hosp, Intens Care Unit, Adelaide, SA 5000, Australia
[2] Royal Adelaide Hosp, Dept Gastroenterol, Adelaide, SA 5000, Australia
[3] Univ Adelaide, Discipline Med, Adelaide, SA, Australia
关键词
critical care; critical illness; gastric emptying; gastrointestinal motility; prokinetics; SMALL-BOWEL MOTILITY; PARACETAMOL ABSORPTION; ENTERAL NUTRITION; GASTRIC-MOTILITY; CARE PATIENTS; DOUBLE-BLIND; TEGASEROD; PROPOFOL; TRANSIT; ERYTHROMYCIN;
D O I
10.1097/MCC.0b013e3280523a88
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Purpose of review Enteral nutrition is frequently unsuccessful in the critically ill due to gastrointestinal dysfunction. Current treatment strategies are often disappointing. In this article upper gastrointestinal function in health together with abnormalities seen during critical illness are reviewed, and potential therapeutic options summarized. Recent findings Reflux oesophagitis occurs frequently due to reduced or absent lower oesophageal sphincter tone. In the stomach a number of motor patterns contribute to slow gastric emptying. The fundus has reduced compliance, there are less frequent contractions in both the proximal and distal stomach, isolated pyloric activity is increased and the organization of duodenal motor activity is abnormal. In response to nutrients, enterogastric feedback is enhanced, fundic relaxation and subsequent recovery is delayed, antral motility is further reduced and localized pyloric contractions stimulated. Elevated concentrations of hormones such as cholecystokinin and peptide YY are potential mediators for these phenomena. Rapid tachyphylaxis occurs with the commonly used prokinetics, metoclopramide and erythromycin, and novel agents are under investigation. Independent of gastric emptying, nutrient absorption is reduced. Summary There has been considerable progress in understanding the pathogenesis of mechanisms causing feed intolerance in critical illness, but this is yet to be translated into therapeutic benefit.
引用
收藏
页码:187 / 194
页数:8
相关论文
共 50 条
  • [1] Gastrointestinal Dysmotility: Clinical Consequences and Management of the Critically Ill Patient
    Chapman, Marianne J.
    Nguyen, Nam Q.
    Deane, Adam M.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2011, 40 (04) : 725 - +
  • [2] Gastrointestinal Motility Disorders in Critically Ill
    Govil, Deepak
    Pal, Divya
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2020, 24 : S179 - S182
  • [3] Treatment of impaired gastrointestinal motility in the critically ill patient
    Herbert, M. K.
    Holzer, P.
    ANASTHESIOLOGIE & INTENSIVMEDIZIN, 2009, 50 : 602 - 615
  • [4] Disturbances of gastrointestinal motility in critically ill patients
    Bittinger, M.
    Messmann, H.
    GASTROENTEROLOGE, 2014, 9 (06): : 527 - 534
  • [5] Gastrointestinal Motility Disorders in Critically Ill Patients
    Grajecki, Donata
    Tacke, Frank
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (11) : 696 - 703
  • [6] Bowel Sounds and Monitoring Gastrointestinal Motility in Critically Ill Patients
    Li, Bing
    Wang, Jian-Rong
    Ma, Yan-Lan
    CLINICAL NURSE SPECIALIST, 2012, 26 (01) : 29 - 34
  • [7] Pathophysiology and Treatment of Gastrointestinal Motility Disorders in the Acutely Ill
    Deane, Adam M.
    Chapman, Marianne J.
    Blaser, Annika Reintam
    McClave, Stephen A.
    Emmanuel, Anton
    NUTRITION IN CLINICAL PRACTICE, 2019, 34 (01) : 23 - 36
  • [8] Gastrointestinal dysfunction relating to the provision of nutrition in the critically ill
    Chapman, Marianne J.
    Deane, Adam M.
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2015, 18 (02) : 207 - 212
  • [9] Gastrointestinal disorders in critically ill patients
    Eikam, M.
    Steinke, T.
    Moritz, S.
    Bucher, M.
    Raspe, C.
    ANASTHESIOLOGIE & INTENSIVMEDIZIN, 2014, 55 : 158 - 180
  • [10] Effects of spinal sympathicolysis on gastrointestinal motility in critically ill patients
    P Wegermann
    M Tryba
    Critical Care, 3 (Suppl 1):